blood cells
ɛ2 cells
relevant cells
identification of new treatment approaches
new diagnostics
new signalling pathways
seminal new finding
risk factors
APOE biology
years
end of ADAPTED
earliest stages of risk identification
lines of human induced pluripotent stem cells
longitudinal ADAPTED cohort
risk factor of LOAD
Treatment Elucidation
AD studies
blood based AD signatures
gene editing
combination of approaches
research path
integrated hypothesis-free approach
pleiotropic influence
research programme
broad approach
rigorous integrated analysis
immune systems pathways
temporal dimension
macrophage-endothelium co-culture
quantitative proteomics assays
bespoke homozygote ɛ3
neuron-astrocyte
Chip models
state-of-the-art omics
Organ
endocytosis
metabolism
data
progression
therapies
Alzheimers Disease Apolipoprotein Pathology
utility
iPSC
phenotype
MCI
predictive capacity
focussed effort
clinical proof of concept
Development APOEɛ4
vision
Testing
follow
results
fundamental study
modulation
backbone
rising tide of suffering
Lipid homeostasis
series of experiments
consortium cohorts
diagnostic consistency
extreme genotypes
complexity
biological mechanisms
validation of biomarkers
vasculature
work
brain